Publications by authors named "Debora Moreno"

Claim this Profile
B
Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective longitudinal study.
Javier García-Corbacho, Alberto Indacochea, Iván Victoria, Débora Moreno, Laura Angelats

Cancer Immunol Immunother· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.
Javier García-Corbacho, Alberto Indacochea, Azucena E González Navarro, Iván Victoria, Débora Moreno

Cancer Immunol Immunother· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.
Javier García-Corbacho, Alberto Indacochea, Azucena E González Navarro, Iván Victoria, Débora Moreno

Cancer Immunol Immunother· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are Silver Nanoparticles Useful for Treating Second-Degree Burns? An Experimental Study in Rats.
Débora Antunes Neto Moreno, Mirela Santos Saladini, Fabia Judice Marques Viroel, Murilo Melo Juste Dini, Thaisa Borim Pickler

Adv Pharm Bull· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of silver nanoparticles on prokaryotic cells and Bothrops jararacussu snake venom.
Isadora Caruso Fontana Oliveira, Marina Oliveira de Paula, Hellen Cristine Boschilha Lastra, Bruno de Brito Alves, Débora Antunes Neto Moreno

Drug Chem Toxicol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A personalized preclinical model to evaluate the metastatic potential of patient-derived colon cancer initiating cells.
Isabel Puig, Irene Chicote, Stephan P Tenbaum, Oriol Arqués, José Raúl Herance, Debora Moreno

Clin Cancer Res· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis